ASTN1 and metabolic dysfunction-associated steatohepatitis: To test the preventive effect of ASTN on HFD-induced NASH (Figure 3A), oral administration of ASTN (80 mg/kg of mouse bodyweight) was performed simultaneously while feeding HFD.